This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Staidson (Beijing) Biopharmaceuticals Co., Ltd, Staidson (Beijing) Biopharmaceuticals Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Pingxia Zhu: Innovator in Biopharmaceuticals
Introduction
Pingxia Zhu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, his work has the potential to impact various medical treatments.
Latest Patents
Pingxia Zhu's latest patents include innovative antibodies specifically recognizing C5A and granulocyte-macrophage colony stimulating factor receptor alpha. The first patent focuses on antibodies that specifically recognize C5A, while the second patent provides antibodies that bind to the Granulocyte-Macrophage Colony Stimulating Factor Receptor (GM-CSFRα). These patents also detail methods for making and using these antibodies, showcasing his expertise in antibody development.
Career Highlights
Throughout his career, Pingxia Zhu has worked with Staidson Biopharmaceuticals, a leading company in the biopharmaceutical industry. His experience in this company has allowed him to contribute to various innovative projects and advancements in the field.
Collaborations
Pingxia Zhu has collaborated with notable colleagues, including Qingshuang Zhang and Qun Huang. These collaborations have further enhanced his research and development efforts in biopharmaceuticals.
Conclusion
Pingxia Zhu is a distinguished inventor whose work in biopharmaceuticals is marked by his innovative patents and collaborations. His contributions to antibody development are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile